Vestar Inc. regulatory update

Vestar Inc. (VSTR) Vestar Inc. (VSTR) has filed a New Drug Application with the FDA for DaunoXome, its proprietary liposomal formulation of the anthracycline anticancer agent daunorubicin for the tr...